JP2011505345A5 - - Google Patents

Download PDF

Info

Publication number
JP2011505345A5
JP2011505345A5 JP2010535349A JP2010535349A JP2011505345A5 JP 2011505345 A5 JP2011505345 A5 JP 2011505345A5 JP 2010535349 A JP2010535349 A JP 2010535349A JP 2010535349 A JP2010535349 A JP 2010535349A JP 2011505345 A5 JP2011505345 A5 JP 2011505345A5
Authority
JP
Japan
Prior art keywords
phe
group
compound according
cyclo
carbamoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010535349A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011505345A (ja
JP5331817B2 (ja
Filing date
Publication date
Priority claimed from ITMI20072266 external-priority patent/ITMI20072266A1/it
Priority claimed from EP07425778A external-priority patent/EP2067786A1/en
Application filed filed Critical
Priority claimed from PCT/EP2008/066081 external-priority patent/WO2009071460A2/en
Publication of JP2011505345A publication Critical patent/JP2011505345A/ja
Publication of JP2011505345A5 publication Critical patent/JP2011505345A5/ja
Application granted granted Critical
Publication of JP5331817B2 publication Critical patent/JP5331817B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010535349A 2007-12-03 2008-11-24 新規な非選択的ソマトスタチン類似体 Active JP5331817B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ITMI20072266 ITMI20072266A1 (it) 2007-12-03 2007-12-03 Nuovi analoghi non selettivi di somatostatina
ITMI2007A002266 2007-12-03
EP07425778A EP2067786A1 (en) 2007-12-07 2007-12-07 Novel non selective analogs of somatostatin
EP07425778.3 2007-12-07
PCT/EP2008/066081 WO2009071460A2 (en) 2007-12-03 2008-11-24 New non-selective somatostatin analogues

Publications (3)

Publication Number Publication Date
JP2011505345A JP2011505345A (ja) 2011-02-24
JP2011505345A5 true JP2011505345A5 (enExample) 2011-08-04
JP5331817B2 JP5331817B2 (ja) 2013-10-30

Family

ID=40667736

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010535349A Active JP5331817B2 (ja) 2007-12-03 2008-11-24 新規な非選択的ソマトスタチン類似体

Country Status (15)

Country Link
US (1) US8937152B2 (enExample)
EP (1) EP2225271B1 (enExample)
JP (1) JP5331817B2 (enExample)
KR (1) KR101500528B1 (enExample)
CN (1) CN101883785B (enExample)
BR (1) BRPI0818978B8 (enExample)
CA (1) CA2702940C (enExample)
CY (1) CY1114490T1 (enExample)
DK (1) DK2225271T3 (enExample)
ES (1) ES2431573T3 (enExample)
HR (1) HRP20130948T1 (enExample)
PL (1) PL2225271T3 (enExample)
PT (1) PT2225271E (enExample)
SI (1) SI2225271T1 (enExample)
WO (1) WO2009071460A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2508531B1 (en) 2007-03-28 2016-10-19 President and Fellows of Harvard College Stitched polypeptides
CN101883785B (zh) * 2007-12-03 2014-01-15 意大利法尔马科有限公司 新的非选择性生长抑素类似物
SI2603600T1 (sl) 2010-08-13 2019-04-30 Aileron Therapeutics, Inc. Peptidomimetični makrocikli
WO2013032012A1 (ja) * 2011-09-04 2013-03-07 株式会社糖鎖工学研究所 糖鎖付加ポリペプチドおよび当該ポリペプチドを含む医薬組成物
TW201806968A (zh) 2011-10-18 2018-03-01 艾利倫治療公司 擬肽巨環化合物
KR102112373B1 (ko) 2012-02-15 2020-05-18 에일러론 테라퓨틱스 인코포레이티드 펩티드모방체 마크로사이클
HK1205454A1 (en) 2012-02-15 2015-12-18 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
WO2014071241A1 (en) 2012-11-01 2014-05-08 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
DK3007704T3 (da) * 2013-06-13 2021-03-29 Antisense Therapeutics Ltd Kombinationsterapi til akromegali
CN103467575B (zh) * 2013-08-22 2016-03-02 深圳翰宇药业股份有限公司 一种帕西瑞肽的制备方法
CN103641894B (zh) * 2013-12-06 2015-10-28 深圳翰宇药业股份有限公司 一种治疗库欣病的多肽药物的制备方法
BR112017005598A2 (pt) 2014-09-24 2017-12-12 Aileron Therapeutics Inc macrociclos peptidomiméticos e usos dos mesmos
CN104447962B (zh) * 2014-12-29 2018-07-17 成都圣诺生物科技股份有限公司 一种合成帕瑞肽的方法
WO2016154058A1 (en) 2015-03-20 2016-09-29 Aileron Therapeutics, Inc. Peptidomimetic macrocycles and uses thereof
WO2020064693A1 (en) * 2018-09-25 2020-04-02 Advanced Accelerator Applications (Italy) Srl Combination therapy
GB201816637D0 (en) * 2018-10-12 2018-11-28 Heptares Therapeutics Ltd Selective somatostatin receptor agonists
US20240165282A1 (en) * 2021-03-04 2024-05-23 Starget Pharma Ltd. Conformational constrained somatostatin receptor 3 peptide ligands and their conjugates and uses thereof
IT202100032615A1 (it) 2021-12-24 2023-06-24 Italfarmaco Spa Uso di un agonista della somatostatina nel trattamento di tumori che esprimono SSTR3
CN119708199A (zh) * 2023-09-27 2025-03-28 钱杭江医药科技(嘉兴)有限公司 生长抑素肽类类似物、螯合物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147327A (en) * 1995-06-29 2012-11-30 Novartis Ag Somatostatin peptides
GB0018891D0 (en) 2000-08-01 2000-09-20 Novartis Ag Organic compounds
US6365380B2 (en) 2000-02-23 2002-04-02 Pcbu Services, Inc. Method for stereoselectively inverting a chiral center of a chemical compound using an enzyme and a metal catalyst
AU2003212430B2 (en) * 2002-03-12 2006-05-25 Noxell Corporation Cosmetic composition comprising double coated pigment
GB0206415D0 (en) 2002-03-19 2002-05-01 Glaxo Group Ltd Deracemisation of amines
GB0300095D0 (en) * 2003-01-03 2003-02-05 Novartis Ag Organic compounds
AR044852A1 (es) * 2003-06-24 2005-10-05 Novartis Ag Una composicion farmaceutica para la administracion parenteral que comprende un analogo de somatostatina
US20060270730A1 (en) * 2003-08-07 2006-11-30 Andreas Katopodis Histone deacetylase inhibitors as immunosuppressants
GB0318682D0 (en) 2003-08-08 2003-09-10 Novartis Ag Organic compounds
EP1522311A1 (fr) * 2003-10-10 2005-04-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Utilisation de la somatostine ou d'un de ses analogues pour préparer un médicament destiné à réguler la réserve folliculaire ovarienne chez la femme non ménopausée
AU2004294269A1 (en) * 2003-11-25 2005-06-16 Novartis Ag Biomarkers for the efficacy of somatostatin analogue treatment
ITFI20040057A1 (it) * 2004-03-10 2004-06-10 Mauro Giuntini Analoghi della somatostatina
GB0428151D0 (en) 2004-12-22 2005-01-26 Novartis Ag Organic compounds
US7824663B2 (en) * 2005-03-10 2010-11-02 Kokyu Alcohol Kogyo Co., Ltd. Lip gloss composition
SI1787658T1 (sl) * 2005-11-10 2012-07-31 Chemi Spa Formulacije z trajnim sproščanjem somatostatin analognih inhibitorjev rastnega hormona
CN101883785B (zh) * 2007-12-03 2014-01-15 意大利法尔马科有限公司 新的非选择性生长抑素类似物

Similar Documents

Publication Publication Date Title
US11732019B2 (en) Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors
JP7397239B2 (ja) インターロイキン－２３受容体のペプチド阻害剤の組成物
CN111093708B (zh) 生物正交组合物
RS66991B1 (sr) Peptidni inhibitori interleukin-23 receptora i njihova primena u lečenju inflamatornih bolesti
HRP20130948T1 (hr) Novi neselektivni analozi somatostatina
CA2416293A1 (en) Somatostatin analogues
JP2010521485A5 (enExample)
JP6704900B2 (ja) ポリオキサゾリン抗体薬物複合体
JP2006509749A5 (enExample)
RU2003105817A (ru) Аналоги соматостатина
JP2009500424A5 (enExample)
JP2019533645A5 (enExample)
JP2020524675A5 (enExample)
EP1503760A1 (en) Camptothecin derivatives and polymeric conjugates thereof
JP2006526590A5 (enExample)
CN113474014A (zh) 放射性免疫缀合物与dna损伤和修复抑制剂组合疗法
JP2010503691A (ja) ７‐エチル‐１０‐ヒドロキシカンプトセシンのマルチアームポリマー複合体を用いた非ホジキンリンパ腫の治療方法
JP2021513990A (ja) 疎水性アウリスタチンｆ化合物およびそのコンジュゲート
JP2004525888A (ja) オリゴまたはポリアルキレングリコール結合トロンビン阻害剤
CN118946368A (zh) 用于治疗代谢病症和肝病的药物制剂和方法
CN1449412A (zh) Dds化合物及其制备方法
JP2007500222A5 (enExample)
RU2018127330A (ru) Композиция, включающая агонист рецептора glp-1 и агонист глюкагонового рецептора, и ее применение
JP2016523825A (ja) 腎毒性活性物質からの保護のための接合体
JP2022535685A (ja) ビオチン部分に結合した生理活性物質、及びその生理活性物質を含む経口投与用組成物